Intrexon to Announce Fourth Quarter and Full Year 2014 Financial Results on Monday, March 2, 2015

GERMANTOWN, Md., Feb. 23, 2015 /PRNewswire/ -- Intrexon Corporation (NYSE: XON) today announced it will release fourth quarter and full year 2014 financial results after the market closes on March 2, 2015.  The Company will host a conference call that day at 5:30 PM ET to discuss the results and provide a general business update.

The conference call may be accessed by dialing 1-888-346-3959 (Domestic US) and 1-412-902-4262 (International) and asking to join the "Intrexon Conference Call."  Participants may also access the live webcast through Intrexon's website in the Investors section under Calendar of Events.

About Intrexon Corporation
Intrexon Corporation (NYSE: XON) is a leader in synthetic biology focused on collaborating with companies in Health, Food, Energy, Environment, and Consumer sectors to create biologically-based products that improve the quality of life and the health of the planet.  Through the Company's proprietary UltraVector^® platform and integrated technology suite, Intrexon provides its partners with industrial-scale design and development of complex biological systems delivering unprecedented control, quality, function, and performance of living cells.  We call our synthetic biology approach Better DNA^®, and we invite you to discover more at www.dna.com.

Safe Harbor Statement
Some of the statements made in this press release are forward-looking statements that involve a number of risks and uncertainties and are made pursuant to the Safe harbor Provisions of the Private Securities Litigation Reform Act of 1995.  These forward-looking statements are based upon Intrexon's current expectations and projections about future events and generally relate to Intrexon's plans, objectives and expectations for the development of Intrexon's business.  Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release. These risks and uncertainties include, but are not limited to, (i) Intrexon's current and future ECCs and joint ventures; (ii) Intrexon's ability to successfully enter new markets or develop additional products, whether with its collaborators or independently; (iii) actual or anticipated variations in Intrexon's operating results; (iv) actual or anticipated fluctuations in Intrexon's competitors' or its collaborators' operating results or changes in their respective growth rates; (v) market conditions in Intrexon's industry; (vi) Intrexon's ability, and the ability of its collaborators, to protect Intrexon's intellectual property and other proprietary rights and technologies; (vii) Intrexon's ability, and the ability of its collaborators, to adapt to changes in laws or regulations and policies; (viii) the rate and degree of market acceptance of any products developed by a collaborator under an ECC or joint venture; (ix) Intrexon's ability to retain and recruit key personnel; (x) Intrexon's financial condition and its estimates regarding expenses, future revenue, capital requirements and needs for additional financing; and (xi) Intrexon's expectations relating to Trans Ova, AquaBounty and any other consolidated subsidiaries including, upon the anticipated closing of the transaction, ActoGeniX. For a discussion of other risks and uncertainties, and other important factors, any of which could cause Intrexon's actual results to differ from those contained in the forward-looking statements, see the section entitled "Risk Factors" in Intrexon's Annual Report on Form 10-K, as well as discussions of potential risks, uncertainties, and other important factors in Intrexon's subsequent filings with the Securities and Exchange Commission. All information in this press release is as of the date of the release, and Intrexon undertakes no duty to update this information unless required by law.

Intrexon Contacts:
Investor Contact:
Christopher Basta
Vice President, Investor Relations
Tel: +1 (561) 410-7052
[email protected]

Corporate Contact:
Marie Rossi, Ph.D. 
Senior Manager, Technical Communications
Tel: +1 (301) 556-9850
[email protected]

SOURCE Intrexon Corporation

Related Links

http://www.intrexon.com